Dawaa Reference

chronic

Weight gain

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Cushing Syndrome - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK470218/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class TS06 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

A very common, nonspecific presenting complaint; management depends entirely on identifying the cause (diet, low thyroid function, medication, Cushing's syndrome) rather than a direct prescription. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A very common, nonspecific presenting complaint; management depends entirely on identifying the cause (diet, low thyroid function, medication, Cushing's syndrome) rather than a direct prescription.

Cautions
  • Rapid weight gain with swelling and breathlessness may indicate heart failure or kidney disease; central weight gain with other features may indicate Cushing's syndrome.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.